These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 18234478)
1. Differential RNA expression between schizophrenic patients and controls of the dystrobrevin binding protein 1 and neuregulin 1 genes in immortalized lymphocytes. Chagnon YC; Roy MA; Bureau A; Mérette C; Maziade M Schizophr Res; 2008 Mar; 100(1-3):281-90. PubMed ID: 18234478 [TBL] [Abstract][Full Text] [Related]
2. Dysbindin-1 and NRG-1 gene expression in immortalized lymphocytes from patients with schizophrenia. Yamamori H; Hashimoto R; Verrall L; Yasuda Y; Ohi K; Fukumoto M; Umeda-Yano S; Ito A; Takeda M J Hum Genet; 2011 Jul; 56(7):478-83. PubMed ID: 21512575 [TBL] [Abstract][Full Text] [Related]
3. Association study of NRG1, DTNBP1, RGS4, G72/G30, and PIP5K2A with schizophrenia and symptom severity in a Hungarian sample. Réthelyi JM; Bakker SC; Polgár P; Czobor P; Strengman E; Pásztor PI; Kahn RS; Bitter I Am J Med Genet B Neuropsychiatr Genet; 2010 Apr; 153B(3):792-801. PubMed ID: 19937977 [TBL] [Abstract][Full Text] [Related]
4. Differential effects of short- and long-term antipsychotic treatment on the expression of neuregulin-1 and ErbB4 receptors in the rat brain. Deng C; Pan B; Hu CH; Han M; Huang XF Psychiatry Res; 2015 Feb; 225(3):347-54. PubMed ID: 25576368 [TBL] [Abstract][Full Text] [Related]
5. [Expressional changes of neuregulin-1 gene mRNA in peripheral blood from schizophrenia patients]. Zhang HX; Li WQ; Zhang HS; Zhang Y; Zhao JP; Lv LX; Yang G Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2011 Dec; 28(6):620-4. PubMed ID: 22161091 [TBL] [Abstract][Full Text] [Related]
6. Genetics of schizophrenia and affective disorders. Maier W; Zobel A; Rietschel M Pharmacopsychiatry; 2003 Nov; 36 Suppl 3():S195-202. PubMed ID: 14677079 [TBL] [Abstract][Full Text] [Related]
8. Decreased Neuregulin 1 C-terminal fragment in Brodmann's area 6 of patients with schizophrenia. Barakat A; Dean B; Scarr E; Evin G Schizophr Res; 2010 Dec; 124(1-3):200-7. PubMed ID: 20926259 [TBL] [Abstract][Full Text] [Related]
9. The role of DTNBP1, NRG1, and AKT1 in the genetics of schizophrenia in Finland. Turunen JA; Peltonen JO; Pietiläinen OP; Hennah W; Loukola A; Paunio T; Silander K; Ekelund J; Varilo T; Partonen T; Lönnqvist J; Peltonen L Schizophr Res; 2007 Mar; 91(1-3):27-36. PubMed ID: 17300918 [TBL] [Abstract][Full Text] [Related]
10. The effect of COMT, BDNF, 5-HTT, NRG1 and DTNBP1 genes on hippocampal and lateral ventricular volume in psychosis. Dutt A; McDonald C; Dempster E; Prata D; Shaikh M; Williams I; Schulze K; Marshall N; Walshe M; Allin M; Collier D; Murray R; Bramon E Psychol Med; 2009 Nov; 39(11):1783-97. PubMed ID: 19573260 [TBL] [Abstract][Full Text] [Related]
11. Antipsychotic drugs attenuate aberrant DNA methylation of DTNBP1 (dysbindin) promoter in saliva and post-mortem brain of patients with schizophrenia and Psychotic bipolar disorder. Abdolmaleky HM; Pajouhanfar S; Faghankhani M; Joghataei MT; Mostafavi A; Thiagalingam S Am J Med Genet B Neuropsychiatr Genet; 2015 Dec; 168(8):687-96. PubMed ID: 26285059 [TBL] [Abstract][Full Text] [Related]
12. Are high-risk haplotypes in DTNBP1 and NRG1 resistance genes for schizophrenia? Doi N; Usui C Am J Psychiatry; 2006 May; 163(5):940-1; author reply 941-2. PubMed ID: 16648345 [No Abstract] [Full Text] [Related]
13. Lack of association to a NRG1 missense polymorphism in schizophrenia or bipolar disorder in a Costa Rican population. Moon E; Rollins B; Mesén A; Sequeira A; Myers RM; Akil H; Watson SJ; Barchas J; Jones EG; Schatzberg A; Bunney WE; DeLisi LE; Byerley W; Vawter MP Schizophr Res; 2011 Sep; 131(1-3):52-7. PubMed ID: 21745728 [TBL] [Abstract][Full Text] [Related]
14. Common risk genes for affective and schizophrenic psychoses. Maier W Eur Arch Psychiatry Clin Neurosci; 2008 Jun; 258 Suppl 2():37-40. PubMed ID: 18516516 [TBL] [Abstract][Full Text] [Related]
15. Effects of NRG1 genotypes on orbitofrontal sulcogyral patterns in Japanese patients diagnosed with schizophrenia. Yoshimi A; Suda A; Hayano F; Nakamura M; Aoyama-Uehara K; Konishi J; Asami T; Kishida I; Kawanishi C; Inoue T; McCarley RW; Shenton ME; Hirayasu Y Psychiatry Clin Neurosci; 2016 Jul; 70(7):261-8. PubMed ID: 26909665 [TBL] [Abstract][Full Text] [Related]
16. Gene expression of neuregulin-1 isoforms in different brain regions of elderly schizophrenia patients. Parlapani E; Schmitt A; Wirths O; Bauer M; Sommer C; Rueb U; Skowronek MH; Treutlein J; Petroianu GA; Rietschel M; Falkai P World J Biol Psychiatry; 2010 Mar; 11(2 Pt 2):243-50. PubMed ID: 20218788 [TBL] [Abstract][Full Text] [Related]
17. Support for neuregulin 1 as a susceptibility gene for bipolar disorder and schizophrenia. Georgieva L; Dimitrova A; Ivanov D; Nikolov I; Williams NM; Grozeva D; Zaharieva I; Toncheva D; Owen MJ; Kirov G; O'Donovan MC Biol Psychiatry; 2008 Sep; 64(5):419-27. PubMed ID: 18466881 [TBL] [Abstract][Full Text] [Related]
18. DTNBP1, NRG1, DAOA, DAO and GRM3 polymorphisms and schizophrenia: an association study. Jönsson EG; Saetre P; Vares M; Andreou D; Larsson K; Timm S; Rasmussen HB; Djurovic S; Melle I; Andreassen OA; Agartz I; Werge T; Hall H; Terenius L Neuropsychobiology; 2009; 59(3):142-50. PubMed ID: 19439994 [TBL] [Abstract][Full Text] [Related]
19. Analysis of a promoter polymorphism in the SMDF neuregulin 1 isoform in Schizophrenia. Pedrosa E; Nolan KA; Stefanescu R; Herskovits P; Novak T; Zukov I; Stopkova P; Lachman HM Neuropsychobiology; 2009; 59(4):205-12. PubMed ID: 19521112 [TBL] [Abstract][Full Text] [Related]
20. The contribution of three strong candidate schizophrenia susceptibility genes in demographically distinct populations. Hall D; Gogos JA; Karayiorgou M Genes Brain Behav; 2004 Aug; 3(4):240-8. PubMed ID: 15248869 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]